RBPs, that include Musashi2, heterogeneous nuclear ribonucleoprotein H1, hnRNPA1, and others, have been implicated in CML [28–32]. Here, HNRNPA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.